Mentions
Extended reach
Total likes
Video views
AI synopsis
Many discussions emphasize the significance of proper missing data management, with phrases like 'helpful paper' and mentions of its practical flowcharts, indicating interest in applying these methods. The tone suggests a cautious but positive perception about the article's utility, with users showing curiosity about the implications for research quality and bias reduction.
Most discussions support the importance of proper handling of missing data and the usefulness of the article, though some show tentative or cautious approval.
Posts indicate moderate curiosity, referencing the practical aspects of the guide and mentioning related concepts like missing data and statistical power.
Several discussions mention the application of methods like multiple imputation, implying active consideration of the article's methods and implications.
Participants recognize the article’s relevance to improving research practices in clinical trials, perceiving it as potentially influential for methodology improvement.
欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス https://t.co/IIF3O8dEyw
#MethodMonday 27: Missing data in clinical trials https://t.co/XgSDr0rkD5 https://t.co/9qDM8gftgF Missing data in trials decreases statistical power and may lead to bias, as those with missing data are often different from those without. 1/..
Writing up a randomized controlled trial (#RCT), helpful paper on missing data approaches: https://t.co/GrOgXuS8Vs
@JamesEBartlett https://t.co/CIxoiEH9i2
@NoahHaber @tmorris_mrc @ProfMattFox https://t.co/j04CExIzSP I’m leaving this here to see what people think https://t.co/zAA3ppT3lH
A little #FridayFunny heading into the weekend
Handling missing data in randomized clinical trials is essential to avoid bias. The authors emphasize planning from the start, using methods like multiple imputation, and following structured flowcharts for reliable…
Handling missing data in randomized clinical trials is crucial to prevent bias. This video offers a practical guide with flowcharts on when and how to use multiple imputation and sensitivity analyses, emphasizing the…
Handling missing data in randomized clinical trials is crucial to avoid bias. This video provides practical guidance on when and how to apply multiple imputation, including decision flowcharts, to ensure valid and…
Handling missing data in randomized clinical trials is crucial to prevent bias. The authors emphasize planning for missing data from the start and using methods like multiple imputation and sensitivity analyses, guided…
Handling missing data in randomized clinical trials is crucial to avoid bias. This video offers practical guidance on planning for missing data, utilizing multiple imputation, and applying structured flowcharts to…
Handling missing data in randomized clinical trials is essential to avoid bias; planning from the outset is crucial. This video discusses methods like multiple imputation and sensitivity analyses, supported by practical…
Handling missing data in randomized trials is vital to prevent bias. The authors recommend planning early, using multiple imputation, sensitivity analyses, and following structured decision flowcharts to ensure accurate…
Handling missing data in clinical trials is essential to avoid bias. This video explains when and how to use multiple imputation and sensitivity analyses, emphasizing planning from the start and following structured…
Handling missing data in randomized clinical trials is crucial because it can bias results if not managed properly. The video provides practical guidance on when and how to use multiple imputation, including flowcharts…
Handling missing data in randomized clinical trials is essential to avoid bias. This video guides researchers through planning, selecting methods like multiple imputation, and using flowcharts to ensure valid, reliable…
Jakobsen, J. C., Gluud, C., Wetterslev, J., & Winkel, P. (2017). When and how should multiple imputation be used for handling missing data in randomised clinical trials—A practical guide with flowcharts. BMC Med Res Methodol, 17(1), Article 1. https://t.co/ujpFVFma2F
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
RT @so_flat: 欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス…
欠測割合がどのくらいまで多重補完するか？ MIの意思決定に欠測割合40％カットオフにしたフローチャートの論文（2017） https://t.co/SxtgyiRLIQ Harrellらは、どのような割合でもMIをやったほうがよいというニュアンス https://t.co/IIF3O8dEyw
RT @andersgranholm: #MethodMonday 27: Missing data in clinical trials https://t.co/XgSDr0rkD5 https://t.co/9qDM8gftgF Missing data in tria…
RT @andersgranholm: #MethodMonday 27: Missing data in clinical trials https://t.co/XgSDr0rkD5 https://t.co/9qDM8gftgF Missing data in tria…
RT @andersgranholm: #MethodMonday 27: Missing data in clinical trials https://t.co/XgSDr0rkD5 https://t.co/9qDM8gftgF Missing data in tria…
RT @andersgranholm: #MethodMonday 27: Missing data in clinical trials https://t.co/XgSDr0rkD5 https://t.co/9qDM8gftgF Missing data in tria…
#MethodMonday 27: Missing data in clinical trials https://t.co/XgSDr0rkD5 https://t.co/9qDM8gftgF Missing data in trials decreases statistical power and may lead to bias, as those with missing data are often different from those without. 1/..
あとでよむ。 https://t.co/QJSr1ODhBW
When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts. https://t.co/uWvnBbEWTo
A little #FridayFunny heading into the weekend
When and how should multiple imputation be used for handling missing data in randomised clinical trials – a practical guide with flowcharts https://t.co/jBWHN0LbVU
無作為化臨床試験における解析に限らず基本的に大事なことでは？ https://t.co/mgl7gReahg
RT @GuyProchilo: @JamesEBartlett https://t.co/CIxoiEH9i2
@JamesEBartlett https://t.co/CIxoiEH9i2
@akhilanekkanti @drkatemills This might be helpful but I haven't read it yet! https://t.co/i0qATv8Wi2
@NoahHaber @tmorris_mrc @ProfMattFox https://t.co/j04CExIzSP I’m leaving this here to see what people think https://t.co/zAA3ppT3lH
Writing up a randomized controlled trial (#RCT), helpful paper on missing data approaches: https://t.co/GrOgXuS8Vs